Contact: Tim Gehret
843.792.2626
April 25, 2006
"We're not talking about minor changes. We are talking about major changes that will cross institutional boundaries." -Perry Halushka, Ph.D., MD, MUSC researcher
CHARLESTON -- MUSC is bridging the gap between groundbreaking research taking place in the laboratory and how it is applied to patient care.
The Clinical and Translational Science Awards (CTSA) program, established by the National Institutes of Health (NIH), has been described as the most significant strategic opportunity facing academic health centers for the past 50 years. It's an initiative that could mean tens of millions of federal dollars for MUSC.
Tuesday, April 25, Raymond S. Greenberg, MD, PhD, MUSC President, announced specifics of the program which include each of the six colleges, their deans, and teams of top researchers and stakeholders that will ensure that what is developed in the labs, will be known by clinicians, and then applied in clinical settings.
"Given the great disparities in health within the population of South Carolina, our focus appropriately enough, will be on many of the conditions that contribute to these disparities," Greenberg said.
"Ultimately, patients will be better served because new prevention strategies and treatments will be developed, tested, and brought into medical practice more rapidly." NIH's D Elias A. Zerhouni, M.D., National Institute of Health.
#####